US EditionClinical Trial: Full-Spectrum Cannabis Extract Improves Core Symptoms of Rett Syndrome and Reduces Caregiver Burden
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Clinical Trial: Full-Spectrum Cannabis Extract Improves Core Symptoms of Rett Syndrome and Reduces Caregiver Burden
The Marijuana Herald - Marijuana news and information A Phase I/II clinical trial published today by the Journal of Paediatrics and Child Health has found that NTI164, a low-THC full-spectrum cannabis extract, can significantly improve the core symptoms associated with Rett syndrome (RTT), a rare neurodevelopmental disorder. Conducted over 12 weeks, the open-label trial administered NTI164 to 11 girls between the ages of 5 and 16, each diagnosed…
A team from the University of Valencia (UV) has identified how early stress alters the morphology of immune cells in the brain, microglia, in mice carrying a mutation of the Mecp2 gene associated with Rett syndrome, a rare and very serious neurodevelopmental disease that mainly affects women and causes multiple symptoms, such as loss of speech and intellectual disability. Cell changes occur in a brain region key to the response to pain and stres…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
